Related Experiment Video
Updated: Jul 4, 2026
10:35
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome
Marc Lambert1, David Launay, Eric Hachulla
1Department of Internal Medicine and Faculty of Medicine, University of Lille II, Hospital Huriez, CHRU, Lille Cedex, France.
Critical Care Medicine
|June 17, 2008
Summary
High-dose intravenous immunoglobulins (IVIG) dramatically improved patients with systemic capillary leak syndrome (SCLS), a rare disorder. This treatment offers a new therapeutic option for SCLS, improving long-term survival.
Area of Science:
- Immunology
- Hematology
- Rare Diseases
Background:
- Systemic capillary leak syndrome (SCLS) is a rare, life-threatening disorder characterized by unexplained capillary fluid extravasation.
- Clinical manifestations include hypotension, shock, weight gain, hypoalbuminemia, and elevated hematocrit.
- Current SCLS treatment is primarily supportive due to unknown etiology.
Observation:
- A patient with refractory SCLS experienced dramatic improvement following high-dose intravenous immunoglobulin (IVIG) administration.
- This patient remains alive 11 years post-diagnosis and receives monthly IVIG maintenance therapy.
- Subsequently, two additional SCLS patients showed positive outcomes with IVIG during acute phases.
Findings:
- IVIG administration led to sustained survival in three SCLS patients, with follow-up periods of 11, 8, and 1.5 years.
- All treated patients received IVIG during acute SCLS flares or as maintenance therapy.
- The study demonstrates the efficacy of IVIG in managing SCLS symptoms and improving patient prognosis.
Implications:
- High-dose IVIG represents a promising therapeutic strategy for systemic capillary leak syndrome.
- Further research into the immunomodulatory mechanisms of IVIG in SCLS is warranted.
- This approach may significantly alter the management and long-term outlook for SCLS patients.
Related Concept Videos
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...